Bank Nifty rebounded from crucial support on Wednesday after Non-Financial stock came under selling pressure while USDINR reactivated monthly breakout on close above 73.60 for a potential target of 77.50. There is a direct negative correlation in USDINR and Bank Nifty and hence we may see wild swings in Bank Nifty in days to come. The Bank Nifty which so far has underperformed the Nifty by 15%, may see trigger for 25% downside if it breaks 35845. In Nifty, critical support is seen at 17214, below which candlestick will confirm major trend reversal.
U.S indices ended lower on Wednesday, led by worries that the Delta coronavirus variant could blunt the economy’s recovery and on uncertainty about when the US Federal Reserve may pull back its accommodative policies. The Dow Jones Industrial Average fell 0.2% to end at 35,031.07 points, while the S&P 500 lost 0.13% to 4,514.07. The Nasdaq Composite dropped 0.57% to 15,286.64. Asian markets fell as investors reacted to the release of China’s August inflation data.
Stocks in news
TCS: Avianca, one of the leading airlines in South America, partnered with TCS to accelerate its journey to the cloud.
Infosys :The company and The Economist Group announced a new strategic partnership designed to enable and accelerate sustainability solutions and drive world-changing impact through a new business-to-business model.
Aurobindo Pharma: The company received US FDA nod for anti-bacterial drug Daptomycin.
Piramal Enterprises: The company arm Piramal Critical Care received US FDA nod for generic of Sedative Precedex.
Suven Pharma: The company received US FDA nod for malaria drug Chloroquine Phosphate.
UCO Bank: RBI lifted Prompt Corrective Action restrictions on UCO Bank.
ONGC: ICRA has assigned ‘AAA’ credit rating for non-convertible debentures (NCD) of the company for Rs 7,500 crore.
Must Read: ITR Filing Online Process Step-By-Step
A financial planning platform where you can plan all your goals, cash flows, expenses management, etc., which provides you advisory on the go. Unbiased and with uttermost data security, create your Financial Planning without any cost on: http://bit.ly/Robo-Fintoo
Disclaimer: The views shared in blogs are based on personal opinion and does not endorse the company’s views. Investment is a subject matter of solicitation and one should consult a Financial Adviser before making any investment using the app. Making an investment using the app is the sole decision of the investor and the company or any of its communication cannot be held responsible for it.
